NCT03312257View on ClinicalTrials.gov

Bifocal & Atropine in Myopia (BAM) Study

NACompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

June 30, 2020

Study Completion Date

June 30, 2020

Conditions
Refractive Errors
Interventions
COMBINATION_PRODUCT

Multifocal D +2.50 add & 0.01% atropine

Biofinity Multifocal D +2.50 add is a monthly disposable contact lens commercially available from CooperVision; 0.01% atropine is low-dose atropine compounded by local pharmacy.

All Listed Sponsors
lead

Jenny Jones

OTHER

NCT03312257 - Bifocal & Atropine in Myopia (BAM) Study | Biotech Hunter | Biotech Hunter